This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Lacrimal Apparatus Diseases
Information about Lacrimal Apparatus Diseases: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Lacrimal Apparatus Diseases
Most recent studies have shown that Lacrimal Apparatus Diseases shares some biological mechanisms with adenocarcinoma, adenoid-cystic-carcinoma, adenoma, carcinoma, conjunctival-diseases, edema, excessive-tearing, eye-neoplasms, eyelid-diseases, inflammation, lacrimal-duct-obstruction, lymphoma, malignant-neoplasms, malignant-paraganglionic-neoplasm, mixed-salivary-gland-tumor, neoplasms, orbit-(eye-disorders), orbital-neoplasms, stenosis.
Among the many pathways, these few ones have gauged particular interests from scientists studying Lacrimal Apparatus Diseases, and have been seen in publications frequently: Aging, B Cell Proliferation, Cell Proliferation, Dehiscence, Enucleation, Granuloma Formation, Innervation, Keratinization, Localization, Mitosis, Pathogenesis, Pigmentation, Reflex, Regeneration, Secretion, Tear Secretion, Translation, Transport, Transposition, Wound Healing
Quite a number of genes have been found to play important roles in Lacrimal Apparatus Diseases, such as AAAS, ACACA, CD34, CTLA4, DCXR, GFAP, HLA-DQA1, KRT20, LYZ, MID1, NOD2, POMC, SLC17A5, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.